Literature DB >> 19350281

Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Yaojun Liang1, Yu Jin, Yuning Li.   

Abstract

The objective of this study was to investigate the role of the Janus kinase-signal transducers and activators of transcription (JAKs/STATs) pathway in focal segmental glomerulosclerosis. Sixty specific pathogen-free male Wistar rats were randomly divided into two groups: a model group (MG) and a control group (CG). In the MG group, nephropathy was induced by unilateral nephrectomy and a single tail vein injection of adriamycin (5 mg/kg). Ten rats were sacrificed every 2 weeks in each group. The expressions of smooth muscle alpha actin (alpha-SMA), collagen (COL)-IV, STAT1, and STAT3 were examined using histochemical techniques, and Western blotting was used to examine the protein levels of STAT1, STAT3, phosphorylated (P)-STAT1, P-STAT3, and transforming growth factor beta1 (TGFbeta(1)). The expressions of JAK1, JAK2, STAT1, STAT3, suppressors of cytokine signaling (SOCS)1, SOCS3, protein inhibitors of activated STAT (PIAS)1, and PIAS3 were also measured by real-time quantitative reverse transcriptase-PCR. A steady and significant increase in the expressions of alpha-SMA, COL-IV and TGFbeta(1) were observed in MG rats over the whole experimental course. Increased STAT1 and P-STAT1 levels in MG rats were observed by week 6, whereas increased levels of STAT3 and P-STAT3 were noted by week 2. At the mRNA levels, JAK1, STAT1, and PIAS1 were significantly increased in MG rats in week 2, whereas JAK2 mRNA showed a significant decrease by weeks 2 and 4, followed by an significant increase in week 6. Significantly increased STAT3 levels were noted in week 2, followed by a steady and significant decrease in weeks 4 and 6. Significantly reduced levels of SOCS1, SOCS3, and PIAS3 mRNA were noted at all time points. We conclude that the JAKs/STATs signaling pathway may play an important role in the pathological process of rapid focal segmental glomerulosclerosis in the rat model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350281     DOI: 10.1007/s00467-009-1163-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  33 in total

Review 1.  Jak-STAT signaling pathways in cells of the immune system.

Authors:  L B Ivashkiv
Journal:  Rev Immunogenet       Date:  2000

Review 2.  Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.

Authors:  Robert N Cooney
Journal:  Shock       Date:  2002-02       Impact factor: 3.454

Review 3.  Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment.

Authors:  H Shiiki; K Dohi
Journal:  Intern Med       Date:  2000-08       Impact factor: 1.271

Review 4.  Inhibitors of cytokine signal transduction.

Authors:  Samuel Wormald; Douglas J Hilton
Journal:  J Biol Chem       Date:  2003-11-07       Impact factor: 5.157

Review 5.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

6.  Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy.

Authors:  S A Mezzano; M A Droguett; M E Burgos; L G Ardiles; C A Aros; I Caorsi; J Egido
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

Review 7.  The suppressors of cytokine signalling (SOCS).

Authors:  B T Kile; W S Alexander
Journal:  Cell Mol Life Sci       Date:  2001-10       Impact factor: 9.261

Review 8.  STAT1 as a key modulator of cell death.

Authors:  Hun Sik Kim; Myung-Shik Lee
Journal:  Cell Signal       Date:  2006-09-30       Impact factor: 4.315

9.  Fluvastatin inhibits activation of JAK and STAT proteins in diabetic rat glomeruli and mesangial cells under high glucose conditions.

Authors:  Yong-hong Shi; Song Zhao; Chen Wang; Ying Li; Hui-jun Duan
Journal:  Acta Pharmacol Sin       Date:  2007-12       Impact factor: 6.150

10.  Focal segmental glomerulosclerosis--epidemiology aspects in children and adults.

Authors:  Ronald Hogg; John Middleton; V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2006-12-07       Impact factor: 3.714

View more
  7 in total

1.  Inhibition of integrin α2β1 ameliorates glomerular injury.

Authors:  Corina M Borza; Yan Su; Xiwu Chen; Ling Yu; Stacey Mont; Sergei Chetyrkin; Paul Voziyan; Billy G Hudson; Paul C Billings; Hyunil Jo; Joel S Bennett; William F Degrado; Beate Eckes; Roy Zent; Ambra Pozzi
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

2.  Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome.

Authors:  Piming Zhao; Gizachew B Tassew; Joanna Y Lee; Babak Oskouian; Denise P Muñoz; Jeffrey B Hodgin; Gordon L Watson; Felicia Tang; Jen-Yeu Wang; Jinghui Luo; Yingbao Yang; Sarah King; Ronald M Krauss; Nancy Keller; Julie D Saba
Journal:  JCI Insight       Date:  2021-04-22

3.  Swimming exercise prevents fibrogenesis in chronic kidney disease by inhibiting the myofibroblast transdifferentiation.

Authors:  Chiung-Chi Peng; Kuan-Chou Chen; Chiu-Lan Hsieh; Robert Y Peng
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

4.  The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells.

Authors:  Xuesen Yang; Genlin He; Yutong Hao; Chunhai Chen; Maoquan Li; Yuan Wang; Guangbin Zhang; Zhengping Yu
Journal:  J Neuroinflammation       Date:  2010-09-09       Impact factor: 8.322

Review 5.  Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Huixia Wang; Jiaxing Wang; Yumin Xia
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

6.  The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3.

Authors:  Ágnes Németh; Miklós M Mózes; Laurent Calvier; Georg Hansmann; Gábor Kökény
Journal:  BMC Nephrol       Date:  2019-07-05       Impact factor: 2.388

Review 7.  Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases.

Authors:  Lili Gai; Yuting Zhu; Chun Zhang; Xianfang Meng
Journal:  Cells       Date:  2021-06-27       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.